Disposition of 1540 shares by Gary Corona of Medtronic PLC at 80.0 subject to Rule 16b-3
| MDT Stock | USD 84.74 0.63 0.75% |
Slightly above 52% of Medtronic PLC's investor base is interested to short. The analysis of overall sentiment of trading Medtronic PLC stock suggests that many investors are impartial at this time. Medtronic PLC's investing sentiment can be driven by a variety of factors including economic data, Medtronic PLC's earnings reports, geopolitical events, and overall market trends.
Medtronic |
Filed transaction by Medtronic PLC Officer Interim Cfo. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Read at macroaxis.com
Medtronic PLC Fundamental Analysis
We analyze Medtronic PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medtronic PLC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medtronic PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Revenue
Revenue Comparative Analysis
Medtronic PLC is currently under evaluation in revenue category among its peers. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Medtronic PLC Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Medtronic PLC stock to make a market-neutral strategy. Peer analysis of Medtronic PLC could also be used in its relative valuation, which is a method of valuing Medtronic PLC by comparing valuation metrics with similar companies.
Peers
Medtronic PLC Related Equities
| TNDM | Tandem Diabetes | 1.96 | ||||
| ALGN | Align Technology | 1.94 | ||||
| BSX | Boston Scientific | 1.47 | ||||
| EW | Edwards Lifesciences | 1.21 | ||||
| SYK | Stryker | 1.16 | ||||
| ABT | Abbott Laboratories | 1.15 | ||||
| ZBH | Zimmer Biomet | 0.80 | ||||
| DXCM | DexCom | 1.04 | ||||
| PODD | Insulet | 1.72 |
Additional Tools for Medtronic Stock Analysis
When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.